PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31061533 ↗2019Reported benefit

Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis.

MouseIschaemia-reperfusionCardiacC57BL/6MaleStarted after myocardial infarction; the exact interval is not stated in the ab…

Model: Myocardial infarction produced by ligation of the left anterior descending coronary artery

Irisin alleviated cardiac dysfunction and ventricular dilation at four weeks after myocardial infarction, reduced infarct size and fibrosis, increased angiogenesis in the infarct border zone and reduced cardiomyocyte apoptosis without affecting cardiomyocyte proliferation. In endothelial cells iris…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.